Ultragenyx
RARE
$15.09+1.28%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
$2.79B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$673.00M
EPS (TTM)
$-5.83
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-85.44%
Beta
0.24
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported RARE revenue for 2025-12-31 was $673.0M. Net income was -$575.0M. Revenue was up 20.1% from 2024-12-31 to 2025-12-31. RARE currently screens at market cap $2.79B.
Use this RARE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RARE income, balance, and cash tables.
Ultragenyx (RARE) is a biotechnology company in the Healthcare sector.
Latest cached Ultragenyx (RARE) revenue for Dec 31, 2025 was $673.0M. Net income was -$575.0M. Statements: https://lician.com/financials/rare
Ultragenyx (RARE) market capitalization is $2.79B on the latest cached snapshot.
Ultragenyx (RARE) cached previous close $14.90; day range $14.87 – $15.09; volume 1,519,186. Session quote: https://lician.com/quote/rare
Ultragenyx (RARE) latest cached earnings event is "RARE earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings